Cost & Access
    2026 Guide

    How to Get Semaglutide or Tirzepatide Without Insurance in 2026

    A complete guide to affordable GLP-1 access including compounding options, savings programs, and patient assistance.

    Last updated: December 5, 202518 min read

    Patients without insurance often have to compare brand cash-pay pricing, manufacturer support options, telehealth programs, and legitimate compounded-access routes. This guide focuses on how to evaluate those options safely and how to avoid stale price claims when comparing semaglutide or tirzepatide access.

    Current Cost Overview (2026)

    GLP-1 Medication Costs Without Insurance

    MedicationBrand Cash-PayCompoundedTelehealth Programs
    Semaglutide (Wegovy)Verify current manufacturer cash-pay termsVaries by prescriber and pharmacy workflowVaries by program inclusions and support model
    Tirzepatide (Zepbound)Verify current manufacturer cash-pay termsVaries by access route and regulatory contextVaries by program inclusions and support model

    Compounded GLP-1 Medications

    Compounded semaglutide and tirzepatide offer significant savings while maintaining quality and safety when sourced from legitimate pharmacies.

    What Is Compounding?

    Compounding pharmacies create customized medications based on a doctor's prescription. Regulatory context, shortage status, and pharmacy type all matter here, so patients should avoid articles that treat every compounded-access question as identical across products and dates.

    Safe Compounding Pharmacy Checklist

    • FDA-registered 503B outsourcing facility
    • State pharmacy board licensed
    • Uses USP-grade ingredients with certificates of analysis
    • Third-party potency and sterility testing
    • Based in the United States
    • Requires valid prescription from licensed provider

    Compounded Medication Costs

    Compounded Semaglutide

    • Monthly cost: Varies by pharmacy, formulation, and support model
    • Annual savings: Depends on current brand cash-pay pricing and total program fees
    • Availability: Widely available
    • Forms: Injectable, sublingual

    Compounded Tirzepatide

    • Monthly cost: Varies by access route, pharmacy, and supply conditions
    • Annual savings: Depends on current brand cash-pay pricing and total program fees
    • Availability: Available during shortage
    • Forms: Injectable primarily

    Telehealth Weight Loss Programs

    Telehealth programs offer convenient, all-inclusive access to GLP-1 medications with medical oversight, typically using compounded versions.

    What Telehealth Programs Include

    • Medical consultation: Licensed provider evaluation and prescription
    • Medication: Monthly supply shipped to your door
    • Ongoing support: Regular check-ins and dose adjustments
    • Supplies: Syringes, alcohol swabs, sharps container
    • Messaging: Access to medical team for questions

    Typical Telehealth Program Pricing

    • Semaglutide programs: Pricing varies by what the program includes and how medication is sourced
    • Tirzepatide programs: Pricing varies by current access route, medical support, and supply chain
    • What's included: Medication, consultations, shipping, supplies, and follow-up support should all be confirmed
    • Subscription model: Cancel anytime, no long-term commitment

    Manufacturer Savings Programs

    Both Novo Nordisk (semaglutide) and Eli Lilly (tirzepatide) offer savings programs, though eligibility requirements apply.

    Wegovy Savings Card

    • For commercially insured: Program terms may lower out-of-pocket cost if eligibility requirements are met
    • For uninsured: Verify the current manufacturer offer directly before relying on it
    • Duration: Usually 12-24 months
    • How to enroll: Wegovy.com or through prescriber

    Zepbound Savings Card

    • For commercially insured: Current savings terms should be checked directly with Lilly
    • Cash-pay option: Verify the current direct-purchase terms with Lilly before comparing programs
    • Duration: Variable by program
    • How to enroll: Zepbound.lilly.com

    Patient Assistance Programs

    For patients with limited income and no insurance, manufacturer patient assistance programs (PAPs) may provide free or reduced-cost medication.

    Typical PAP Eligibility Requirements

    • • Income at or below 400% of Federal Poverty Level (approximately $58,000 for individual in 2026)
    • • No prescription drug coverage for the medication
    • • U.S. resident or citizen
    • • Valid prescription from licensed healthcare provider
    • • Application with income documentation required

    How to Apply

    • Novo Nordisk PAP (Wegovy): Call 1-866-310-7549 or visit pap.novonordisk-us.com
    • Lilly Cares (Zepbound): Call 1-800-545-6962 or visit lillycares.com
    • Processing time: 2-4 weeks typically
    • Required documents: Prescription, income verification, application form

    Using HSA and FSA Accounts

    Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA) offer tax-advantaged ways to pay for GLP-1 medications.

    HSA/FSA Benefits for GLP-1 Medications

    What's Covered

    • • FDA-approved weight loss medications with prescription
    • • Compounded semaglutide/tirzepatide with prescription
    • • Medical consultations for weight management
    • • Related supplies (syringes, etc.)

    Tax Savings

    • • HSA: Pre-tax contributions, tax-free growth, tax-free withdrawals for medical expenses
    • • FSA: Pre-tax contributions reduce taxable income
    • • Effective savings: 20-35% depending on tax bracket

    Cost Comparison Table

    OptionMonthly CostAnnual CostBest For
    Brand Wegovy (no insurance)$1,350$16,200Those with insurance coverage
    Compounded semaglutide$200-500$2,400-6,000Budget-conscious patients
    Telehealth programs$199-599$2,388-7,188Convenience seekers
    Patient assistance (if eligible)$0$0Low-income patients
    Zepbound cash-pay$550$6,600Prefer brand-name tirzepatide

    What to Avoid

    Red Flags When Seeking Affordable GLP-1s

    • International pharmacies: Quality control concerns, customs seizures, legal issues
    • No prescription required: Legitimate medications always require prescription
    • Prices too good to be true: May indicate counterfeit or diluted products
    • Social media sellers: High risk of counterfeit medications
    • Unregistered compounding pharmacies: Verify FDA registration
    • No medical oversight: Safe use requires provider monitoring

    Conclusion

    While GLP-1 medications remain expensive without insurance, multiple legitimate pathways exist for affordable access in 2026. Compounded medications from verified pharmacies and comprehensive telehealth programs offer the best value for most uninsured patients.

    Key takeaways:

    • Compounded semaglutide/tirzepatide saves 50-85% compared to brand
    • Telehealth programs offer convenience with all-inclusive pricing
    • Patient assistance programs help low-income patients access brand medications
    • HSA/FSA accounts provide tax advantages for any option
    • Always verify pharmacy credentials and require a prescription

    Ready to Start Your Weight Loss Journey?

    Get affordable access to GLP-1 medications with our all-inclusive program, no insurance required.

    Get Started Today

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program.

    How can patients get GLP-1 treatment without insurance?

    Patients without insurance usually have to compare brand cash-pay pricing, manufacturer support options, and legitimate telehealth or pharmacy-based access routes. The safest approach is to verify current pricing directly with the manufacturer or provider and avoid relying on stale advertised ranges.

    Current pricing can change, so undated cost claims age quickly.
    Patients should compare the total program cost, not just the medicine price line.
    Affordability pages should separate brand cash-pay, savings programs, and compounded-access questions.

    Key Takeaways

    • Without-insurance access depends on current brand pricing, manufacturer programs, and legitimate prescriber/pharmacy pathways.
    • Patients should verify current cash-pay terms directly with the manufacturer or care program instead of trusting old comparison tables.
    • Cost guidance should separate access, safety, and legality rather than collapsing them into one price claim.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: December 5, 2025

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Centers for Medicare & Medicaid Services (2026). Medicare GLP-1 Bridge. CMS.gov.Read Study
    2. NovoCare (2026). Wegovy Price Guide. Novo Nordisk.Read Study
    3. Eli Lilly and Company (2025). Lilly lowers the price of Zepbound single-dose vials. Lilly Investor Relations.Read Study
    4. U.S. Food and Drug Administration (2026). BeSafeRx: Your Source for Online Pharmacy Information. FDA.Read Study

    Was this article helpful?

    Keep Reading

    Every semaglutide pricing option: brand-name, compounded, insurance, and savings programs.

    Complete guide to GLP-1 insurance coverage including Medicare Part D changes, appeals, and alternatives.

    Complete guide to the most affordable GLP-1 medication options in 2026. From compounded semaglutide to manufacturer savings programs — every cost-saving pathway explained.

    Start your GLP-1 journey — from $99/mo